Fixed Price IPO | ₹25 Cr | Listing at NSE SME | Wed, Jun 12, 2019 - Fri, Jun 21, 2019
Sudarshan Pharma Industries IPO is a fixed issue price of ₹24.77 crores. The issue is entirely a fresh issue of 0.34 crore shares of ₹24.77 crore.
Sudarshan Pharma Industries IPO bidding started from Jun 12, 2019 and ended on Jun 21, 2019. The allotment for Sudarshan Pharma Industries IPO was finalized on Jun 20, 2019. Sudarshan Pharma Industries IPO will list on the NSE SME with a tentative listing date fixed as Jun 25, 2019.
Sudarshan Pharma Industries IPO is set final issue price at ₹72 per share. The lot size for an application is 1,600 shares. The minimum amount of investment required by an individual investor (retail) is ₹1,15,200 (1600 shares) (based on upper price). The minimum lot size for investment in HNI is 2 lots (3,200 shares), amounting to ₹2,30,400.
First Overseas Capital Ltd. is the book running lead manager and Kfin Technologies Ltd. is the registrar of the issue. The Market Maker of the company is Safal Capital (India) Ltd.
Refer to Sudarshan Pharma Industries IPO RHP for detailed Information.
IPO Open
Wed, Jun 12, 2019
IPO Close
Fri, Jun 21, 2019
Issue Price
₹72 per share
Market Cap (Pre-IPO)
To be declared
| IPO Date | 12 to 21 Jun, 2019 |
| Listing Date | Tue, Jun 25, 2019T |
| Face Value | ₹10 per share |
| Issue Price | ₹72 per share |
| Lot Size | 1,600 Shares |
| Sale Type | Fresh capital only |
| Issue Type | Fixed Price IPO |
| Listing At | NSE SME |
| Total Issue Size | 34,40,000 shares (agg. up to ₹25 Cr) |
| Reserved for Market Maker | 1,76,000 shares Safal Capital (India) Ltd. (agg. up to ₹1 Cr) |
| Fresh Issue (Ex Market Maker) | 32,64,000 shares (agg. up to ₹24 Cr) |
| Net Offered to Public | 32,64,000 shares (agg. up to ₹24 Cr) |
| Share Holding Pre Issue | 95,46,998 shares |
| Share Holding Post Issue | 1,29,86,998 shares |
Sudarshan Pharma Industries IPO comprises a total issue size of 34,40,000 shares. The net offer to the public is 32,64,000 shares, after excluding 1,76,000 shares allotted on a firm basis. Of the Net offer 16,32,000 (50.00%) allocated to NII 16,32,000 (50.00%) allocated to RII.
| Investor Category | Shares Offered | % of Net Issue | % of Total Issue |
|---|---|---|---|
| NII (HNI) Shares Offered | 16,32,000 | 50.00% | 47.44% |
| Retail Shares Offered | 16,32,000 | 50.00% | 47.44% |
| Firm Reservations | |||
| Market Maker Shares Offered | 1,76,000 | 5.12% | |
| Total Shares Offered | 34,40,000 | 100.00% | 100.00% |
Investors can bid for a minimum of 1,600 shares and in multiples thereof.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 1,600 | ₹1,15,200 |
| Retail (Max) | 1 | 1,600 | ₹1,15,200 |
| HNI (Min) | 2 | 3,200 | ₹2,30,400 |
Incorporated in 2008, Mumbai based Sudarshan Pharma Industries Limited (SPIL) has a contract manufacturing facility to source and supply generic formulations. It is also engaged in import & export activities, and supply of specialty chemicals, API (Active Pharmaceutical Ingredients), and Intermediates. Based on clients' specifications and requirements, they outsource the manufacturing facility from the suppliers in India and abroad.
The generic products supplied by the company have a wide application in paint, food, pharma, and adhesive industry. The company is involved in a contract manufacturing facility, supply and outsource of medicines and pharma formulation to hospitals, NGO, government and healthcare institutes. SPIL has 50 pharma formulations which are supplied under the brand name in the form of tablets, ointment, capsules, and injectable.
The company has its own sales force and distribution network in 5 states for ethical marketing of pharmaceutical formulation & products under the brand name in Indian and international markets. It also offers formulation development and QC services and provides customised solutions.
The competitive strengths of the company are:
1. Customer-centric and order driven business model
2. Wide range of product offerings
3. Contract manufacturing facility arrangements
4. Strong distribution, marketing and sales network
5. Diversified business operations
| Period Ended | 31 Mar 2019 | 31 Mar 2018 | 31 Mar 2017 |
|---|---|---|---|
| Assets | 50.14 | 30.96 | 19.93 |
| Total Income | 140.02 | 89.76 | 55.52 |
| Profit After Tax | 2.35 | 0.74 | 0.16 |
| NET Worth | 18.74 | 8.54 | 3.21 |
| Reserves and Surplus | 9.20 | 3.82 | 1.04 |
| Total Borrowing | 16.95 | 10.29 | 5.77 |
| Amount in ₹ Crore | |||
| Company | Issue Type | Issue Size | Issue Price | PE Ratio | Listing Day Close | Listing Gain/Loss % | LTP |
|---|---|---|---|---|---|---|---|
| Deep Polymers Ltd. | SME | ₹15.24 Cr | ₹40 | null | ₹40.90 | +2.25% | ₹36.70 (+0.80%) |
| Ambani Organics Ltd. | SME | ₹9.03 Cr | ₹66 | null | ₹66.65 | +0.98% | ₹118.00 (+2.56%) |
| Neogen Chemicals Ltd. | Mainboard | ₹132.35 Cr | ₹215 | null | ₹263.55 | +22.58% | ₹2,175.60 (-5.96%) |
| Fine Organic Industries Ltd. | Mainboard | ₹600.17 Cr | ₹783 | null | ₹822.80 | +5.08% | ₹5,056.00 (-0.32%) |
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | To set up a dedicated manufacturing facility for Pharmaceutical Business | 12.50 |
| 2 | Distribution and Warehousing Centre‘s & Purchase of Corporate Office | 4.50 |
| 3 | Additional Working Capital | 5.25 |
| 4 | General Corporate Expenses | 2.80 |
The Sudarshan Pharma Industries IPO IPO subscription status. Full data available on IPOMatrix.com.
| Category | Subscription (times) | Shares Offered | Shares bid for | Total Applications |
|---|---|---|---|---|
| Total | - | - | - | - |
| # | Issue Expenses | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Lead Manager Fees including Underwriting Commission | 0.18 |
| 2 | Market Making Charges for first year of Listing | 0.04 |
| 3 | Fees Payable to Registrar to the Issue | 0.01 |
| 4 | Fees Payable to Advertising and Marketing Expenses | 0.35 |
| 5 | Fees Payable to Regulators including Stock Exchanges | 0.02 |
| 6 | Payment for Printing & Stationery, Distribution, Postage, etc. | 0.02 |
| 7 | Others (Fees Payable to Peer Review Auditor, Fees to Legal Advisors, Marketing Expenses, Brokerage, Processing Fees for Application and Miscellaneous Expenses) | 0.14 |
Date: 24 June 2019
The Company has decided to withdraw the application made for SME IPO on NSE Platform due to material changes in the current business model and future expansion plan. The entire application money will be refunded forthwith.
Lead Manager Reports
Sudarshan Pharma Industries IPO is a SME IPO of 34,40,000 equity shares of the face value of ₹10 aggregating up to ₹25 Crores. The issue is priced at ₹72 per share. The minimum order quantity is 1600.
The IPO opens on Wed, Jun 12, 2019, and closes on Fri, Jun 21, 2019.
Kfin Technologies Ltd. is the registrar for the IPO. The shares are proposed to be listed on NSE SME.
Zerodha customers can apply online in Sudarshan Pharma Industries IPO using UPI as a payment gateway. Zerodha customers can apply in Sudarshan Pharma Industries IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Sudarshan Pharma Industries IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Sudarshan Pharma Industries IPO opens on Wed, Jun 12, 2019 and closes on Fri, Jun 21, 2019.
Sudarshan Pharma Industries IPO lot size is 1600, and the minimum amount required for application is ₹1,15,200.
You can apply in Sudarshan Pharma Industries IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for Sudarshan Pharma Industries IPO will be done on Thursday, June 20, 2019, and the allotted shares will be credited to your demat account by Mon, Jun 24, 2019. Check the Sudarshan Pharma Industries IPO allotment status.
The Sudarshan Pharma Industries IPO listing date is not yet announced. The tentative date of listing is Tue, Jun 25, 2019.
